Oncotarget | MTAP loss in metastatic breast cancer patients: Genomic landscape
“In breast cancer, MTAP downregulation activates ornithine decarboxylase (ODC) which in turn leads to formation of putrescine which promotes tumor migration, invasion and angiogenesis [15].”
BUFFALO, NY- March 14, 2023 – A new research paper was published in Oncotarget's Volume 14 on March 11, 2023, entitled, “Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss.”
Homozygous deletion of methylthioadenosine phosphorylase (MTAP) upregulates de novo synthesis ...














